Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglow M 500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Primus Remedies Pvt Ltd

Salt Composition

Metformin (500mg) + Voglibose (0.3mg)

Overview Voglow M 500mg/0.3mg Tablet

Diabetic patients may find relief with the anti-diabetic medication, Voglow M 500mg/0.3mg Tablet, a dual-action formulation for adult type 2 diabetes management. This medication assists in regulating blood glucose levels. Always take Voglow M with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications including kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle modifications are key to diabetes control. Possible side effects, including nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes, are generally transient. However, persistent or concerning side effects require immediate medical attention. Your doctor can offer management strategies. This medicine is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal dysfunction. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women should consult their physician. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are essential.

Primary Ingredients of Voglow M 500mg/0.3mg Tablet

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Voglow M 500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Voglow M 500mg/0.3mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Voglow M 500mg/0.3mg tablet whole; do not fragment, crush, or chew it. Consumption should coincide with a meal.

Common Side effects of Voglow M 500mg/0.3mg Tablet:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Voglow M 500mg/0.3mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the Voglow M 500mg/0.3mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

How Voglow M 500mg/0.3mg Tablet works:

Each Voglow M 500mg/0.3mg tablet contains a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Voglow M 500mg/0.3mg Tablet ingestion poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglow M 500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Voglow M 500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is generally unaffected by Voglow M 500mg/0.3mg Tablet. Nevertheless, patients using this medication concurrently with other diabetes treatments, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar.

KidneyKidneyCAUTION

Patients with kidney impairment should use Voglow M 500mg/0.3mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. The use of Voglow M 500mg/0.3mg Tablets is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Voglow M 500mg/0.3mg Tablet in individuals with hepatic impairment. Physician consultation is recommended.

What if you forget to take Voglow M 500mg/0.3mg Tablet :

Should you forget to take a Voglow M 500mg/0.3mg Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglow M 500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment
Voglow M 500mg/0.3mg Tabl...
93
MRP 114
18% off